TherapeuticsMD (TXMD) Capital Expenditures (2011 - 2023)
TherapeuticsMD's (TXMD) quarterly Capital Expenditures came in at $2.3 million in Q4 2023, down 69.65% YoY from $7.6 million in Q4 2022, and up 420.53% on a QoQ basis from -$721000.0 in Q3 2023.
TherapeuticsMD (TXMD) Capital Expenditures (2011 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 13 years of Capital Expenditures data on file, last reported at $2.3 million in Q4 2023.
- Quarterly Capital Expenditures fell 69.65% year-over-year to $2.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (down 85.25% YoY) and the FY2023 annual result came in at $1.1 million, down 85.25% from the prior year.
- Capital Expenditures climbed to $2.3 million in Q4 2023, from -$721000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $7.6 million in Q4 2022 to a low of -$721000.0 in Q3 2023.
- A 5-year average of $636277.8 and a median of $41500.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2019 — Capital Expenditures surged 4745.24% — and 2023, when it sank 2200.0%.
- Tracing TXMD's Capital Expenditures over 5 years: stood at $360587.0 in 2019, then slumped by 53.41% to $168000.0 in 2020, then plunged by 141.67% to -$70000.0 in 2021, then surged by 10978.57% to $7.6 million in 2022, then plunged by 69.65% to $2.3 million in 2023.
- The last three Capital Expenditures figures came in at $2.3 million (Q4 2023), -$721000.0 (Q3 2023), and -$483000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.31 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | -721,000.00 |
| Sep 30, 2023 | -721,000.00 |
| Jun 30, 2023 | -483,000.00 |
| Jun 30, 2023 | -483,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 7.62 Mn |
| Dec 31, 2022 | 7.62 Mn |
| Jun 30, 2022 | -21,000.00 |
| Jun 30, 2022 | -21,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Sep 30, 2021 | -70,000.00 |
| Sep 30, 2021 | -70,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Mar 31, 2021 | 63,000.00 |